Browse Title Index

Issue Title File
Vol 10, No 3 (2008) Ot glavnogo redaktora Uvazhaemye kollegi!
Poddubnaya I.V.
Vol 11, No 3 (2009) Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta
Istomin Y.V., Evdokimov M.Y.
Vol 7, No 3 (2005) Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy
Konstantinova M.M., Gershanovich M.L., Akimov M.A., Nosov D.A., Bogdanova N.V.
Vol 3, No 1 (2001) Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov)
Poddubnaya I.V., Khasanov R.S., Ruchkin V.N., Lazarev A.N., Byakhov M.Y., Vtoraya O.M., Yurchenko V.S.
Vol 14, No 2 (2012) Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami
Gafanov R.A., Ivanov S.A., Fastovets S.V., Isaev T.K.
Vol 11, No 3 (2009) Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy
Konstantinova M.M., Savkova R.F., Demidov L.V., Gorbunova V.A., Kharkevich G.Y., Antimonik N.Y., Merkulov V.N., Simanovich E.E., Ral'chenko K.V., Sbrodov O.V.
Vol 3, No 4 (2001) Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM)
Mamedov F.F., Narimanov M.N., Bazin I.S., Efimov O.N., Zharkov S.A., Tryakin A.A., Tyulyandin S.A., Garin A.M.
Vol 26, No 1 (2024) Outcomes of extracorporeal partial nephrectomy in patients with malignant tumors: a retrospective and prospective study PDF
(Rus)
Matveev V.B., Volkova M.I., Sinitsyna O.R., Kuznetsov K.P., Perlin D.V.
Vol 23, No 2 (2021) Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer PDF
(Rus)
Dalgatov K.D., Semenov N.N., Kozodaeva M.V.
Vol 18, No 1 (2016) Outcomes of surgical treatment of advanced gastrointestinal stromal tumors PDF
(Rus)
Abouhaidar O.B., Nered S.N., Arkhiri P.P., Nikulin M.P., Stilidi I.S.
Vol 16, No 1 (2014) Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives
Samoilenko I.V., Kharkevich G.U., Demidov L.V.
Vol 24, No 2 (2022) Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report PDF
(Rus)
Gushchina E.E., Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Khayrullina L.S., Lunin V.V., Fedenko A.A.
Vol 19, No 1 (2017) Own experience of treatment by epoetin-α (Eralfon®) of chemotherapy induced anemia PDF
(Rus)
Bolshakova S.A., Bychkov Y.M., Kazarova M.V.
Vol 24, No 1 (2022) Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62 PDF
(Rus)
PDF
(Eng)
Volkonsky M.V., Zhikhorev R.S., Makarkina T.A., Filippova V.M., Vasileva Y.V., Akopyan A.A., Zhelezkova T.A.
Vol 24, No 4 (2022) Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS)) PDF
(Rus)
Bayazitova R.F.
Vol 26, No 4 (2024) Pain relief clinical efficacy using pulsed radiofrequency ablation of nerve roots in patients with spine metastatic lesions. A prospective study PDF
(Rus)
Kuznetsov S.F., Babkin N.S., Valiev A.K., Kabardaev R.M., Borzov K.A.
Vol 3, No 4 (2001) Paklitaksel (taksol): novye vozmozhnosti. Ezhenedel'nyy rezhim vvedeniya
Voznyy E.K.
Vol 17, No 3 (2015) Pamyati Gianni Bonadonna
- -.
Vol 12, No 3 (2010) Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Artamonova E.V.
Vol 4, No 4 (2002) Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya
Arkad'eva T.V., Ostrizhnaya N.G.
Vol 19, No 2 (2017) PARP inhibitors in female reproductive system cancers PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 24, No 1 (2022) PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary) PDF
(Rus)
Uvarova K.G.
Vol 18, No 2 (2016) Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary PDF
(Rus)
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Vol 15, No 1 (2013) Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
Romanenko N.A.
Vol 22, No 3 (2020) Patient blood management in oncology in the Russian Federation: resolution to improve oncology care. PDF
(Rus)
Hofmann A., Aapro M., Fedorova T.A., Zhiburt Y.B., Snegovoy A.V., Kaganov O.I., Ognerubov N.A., Lyadov V.K., Moiseenko V.M., Trofimova O.P., Ashrafyan L.A., Khasanov R.S., Poddubnaya I.V.
Vol 25, No 4 (2023) Patient resource to improve the effectiveness of oncological care for the population PDF
(Rus)
Kozlov V.A., Samsonov I.V., Mushnikov D.L.
Vol 14, No 3 (2012) Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay)
Savkov R.V.
Vol 8, No 2 (2006) Pemetreksed (alimta)
Tyulyandin S.A.
Vol 3, No 2 (2001) Perifericheskaya neyrotoksichnost' taksotera
Shakirova I.N., Lebedeva L.I., Borisova T.A., Meshcheryakov A.A., Setdikov R.A., Gutorov S.L.
Vol 26, No 3 (2024) Perioperative chemotherapy and morphological response in the treatment of gastric cancer: A retrospective study PDF
(Rus)
Kiselev N.M., Klimin S.A., Kolesnik Y.I., Kokorin R.S., Ashimov E.А., Elagina V.Y., Shumskaya I.S., Zagainov V.E., Gamayunov S.V.
Vol 20, No 2 (2018) Perioperative chemotherapy for gastric cancer: the current state PDF
(Rus)
Lyadov V.K., Pardabekova O.A., Lyadova M.A.
Vol 26, No 4 (2024) Peritoneal lymphomatosis as the only manifestation of diffuse B-cell large cell lymphoma: A clinical case PDF
(Rus)
Ognerubov N.A., Antipova T.S., Poddubnaya I.V.
Vol 16, No 3 (2014) Personalized approach to HER2-positive advanced breast cancertherapy
Stenina M.B.
Vol 25, No 4 (2023) Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review PDF
(Rus)
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
Vol 19, No 2 (2017) Perspectives of pharmacogenetics approach to personalized tamoxifen therapy PDF
(Rus)
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
Vol 5, No 2 (2003) Perspektiva razvitiya khimioterapii s izucheniem etnicheskogo i individual'nogo polimorfizma sistemy tsitokhromov R-450 v Respublike Sakha (Yakutiya)
Ivanova F.G.
Vol 9, No 3 (2007) Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Vol 3, No 3 (2001) Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g
Makarenko N.P.
Vol 14, No 3 (2012) Perspektivy primeneniya ademetionina v komplekse intensivnoy terapii bol'nykh s ostroy pechenochnoy nedostatochnost'yu: vzglyad reanimatologa
Gromova E.G.
Vol 10, No 3 (2008) Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie
Tumyan G.S., Kovrigina A.M., Kichigina M.Y., Sorokin E.N., Bykov D.A., Kondrat'eva T.T., Probatova N.A., Trofimova O.P., Kolomeytsev O.A., Poddubnaya I.V., Tupitsyn N.N., Larionova V.B., Osmanov D.S.
Vol 5, No 1 (2003) Pervichno-mnozhestvennye zlokachestvennye opukholi s porazheniem sosudistoy obolochki glaza
Lerner M.Y.
Vol 8, No 4 (2006) Pervichnye limfomy kozhi: diagnostika i lechenie
Belousova I.E., Krivolapov Y.A.
Vol 3, No 4 (2001) Pervichnye MALT-limfomy zheludka u bol'nykh pozhilogo vozrasta
Moskalenko O.A., Osmanov D.S., Probatova N.A., Kokosadze N.V., Sholokhova E.N., Kovrigina A.I., Kuvshinov Y.P., Poddubnyy B.K., Poddubnaya I.V.
Vol 13, No 4 (2011) Pervichnye nekhodzhkinskielimfomy kostey
Sotnikova O.P., Sorokin E.N., Kovrigina A.M., Bykov D.A., Osmanov E.A., Poddubnaya I.V.
Vol 12, No 2 (2010) Pervyy opyt luchevogo lecheniyaploskokletochnogo raka orofaringeal'noyzony s radiomodifikatsiey tsetuksimabomi tsisplatinom
Boyko A.V., Bolotina L.V., Chernichenko A.V., Gevorkov A.R., Smirnov A.K.
Vol 10, No 3 (2008) Pervyy opyt primeneniya alemtuzumaba u bol'nykh khronicheskim limfoleykozom,refrakternykh k fludarabinsoderzhashchim programmam khimioterapii
Zagoskina T.P., Malykh O.V., Khorobrykh M.N., Dem'yanova V.I., Isaeva N.V., Grishina I.V.
Vol 23, No 4 (2021) Pharmacoeconomic analysis of acalabrutinib in patients with chronic lymphocytic leukemia PDF
(Rus)
Nedogoda S.V., Salasyuk A.S., Barykina I.N., Lutova V.O., Popova E.A.
Vol 19, No 1 (2017) Pharmacoeconomic aspects of biosimilars PDF
(Rus)
Tryakin A.A., Rudakova A.V., Fogt S.N., Vaganov A.S., Tolkacheva D.G.
Vol 19, No 1 (2017) Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin PDF
(Rus)
Kolbin A.S., Mosikyan A.A., Kurilev A.A., Balykina Y.E., Proskurin M.A.
Vol 15, No 4 (2013) Pharmacoeconomic potency assignment of targeted agents in the treatment of metastatic colorectal cancer with wild-type Kras
Yagudina R.I., Poddubnaya I.V., Kulikov A.U.
Vol 16, No 2 (2014) Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
Vol 23, No 2 (2021) Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis PDF
(Rus)
Fedorinov D.S., Geidarov R.N., Shashkov I.A., Mikhailovich V.M., Lyadova M.A., Pokataev I.A., Lyadov V.K.
Vol 23, No 3 (2021) Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS) PDF
(Rus)
Onischuk A.S.
Vol 23, No 3 (2021) Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (Russian Translation of Cochrane Plain Language Summary – PLS) PDF
(Rus)
Sitnikova V.A.
Vol 23, No 2 (2021) PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021 PDF
(Rus)
Board E.
Vol 23, No 1 (2021) Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021 PDF
(Rus)
Board E.
Vol 23, No 3 (2021) Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer PDF
(Rus)
Editorial B.
Vol 24, No 4 (2022) Place of durvalumab in the treatment of biliary tract cancer: A review PDF
(Rus)
Breder V.V., Ledin E.V., Chubenko V.A., Orlova R.V., Petkau V.V., Pokataev I.A.
Vol 20, No 4 (2018) Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results PDF
(Rus)
Dadyev I.A., Davydov M.M., Abdullaev A.G., Kulik I.O., Ambalova Z.A., Akhmedov P.I., Anokhin A.Y., Karasheva B.M.
Vol 6, No 3 (2004) Podavlenie superekspressii protoonkogena ornitindekarboksilazy v adenomatoznykh polipakh tolstoy kishki pri naznachenii bol'nym vysokikh doz folievoy kisloty
Draudin-Krylenko V.A., Mazurov S.T., Levchuk A.A., Orlov E.N., Poddubnyy B.K., Bukin Y.V.
Vol 14, No 3 (2012) Podderzhivayushchaya terapiya nemelkokletochnogo raka legkogo
Gutorov S.L., Borisova E.I.
Vol 14, No 3 (2012) Podderzhivayushchaya terapiya pri metastaticheskom kolorektal'nom rake: odin iz variantov vybora ili novyy standart lecheniya?
Artamonova E.V.
Vol 3, No 3 (2001) Podkhody k profilaktike khirurgicheskoy ranevoy infektsii u onkologicheskikh bol'nykh
Petukhova I.N., Dmitrieva N.V., Varlan G.V.
Vol 14, No 1 (2012) Podvedeny itogi I Vserossiyskoy premiiv oblasti onkologii «IN VITA VERITAS»
- -.
Vol 2, No 2 (2000) Poliklinicheskiy opyt primeneniya arimideksa u bol'nykh rasprostranennym rakom molochnoy zhelezy v menopauze
Potapov S., Kapitonova E.T.
Vol 22, No 3 (2020) Polyploid giant cancer cells and their role in the formation of resistance to therapeutic treatment PDF
(Rus)
Vartanyan N.L., Pinevich A.A., Bode I.I., Samoylovich M.P.
Vol 25, No 2 (2023) Pomalidomide in the management of relapsed/refractory multiple myeloma: A review PDF
(Rus)
Semochkin S.
Vol 6, No 4 (2004) Populyatsionnyy rakovyy registr kak osnova organizatsii tselevykh (skriningovykh) meditsinskikh osmotrov i kontrolya polnoty registratsii zabolevaniy
Cherenkov V.G., Loktionova M.A., Chistyakova T.V.
Vol 21, No 4 (2019) Possibilities of epigenetic therapy of acute myeloid leukemias in children PDF
(Rus)
Seregin G.Z., Lifshits A.V., Аleskerova G.А., Valiev T.T.
Vol 22, No 1 (2020) Possibilities of per-oral transpapillary cholangioscopy in oncological practice PDF
(Rus)
Yurichev I.N., Timofeev M.E., Malikhova O.A., Savosin R.S.
Vol 19, No 1 (2017) Posterior reversible encephalopathy syndrome in children with hematological and oncology diseases PDF
(Rus)
Delyagin V.M., Serdyuk O.A., Balashov D.N., Skvortsova Y.V., Tereshchenko G.V.
Vol 9, No 3 (2007) Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Myasnikova M.O.
Vol 6, No 1 (2004) Pozdnee metastazirovanie granulezokletochnoy opukholi yaichnika
Ivanov Y.V., Solov'ev N.A., Markina R.N., Stepanov V.A., Sokolova N.V.
Vol 8, No 1 (2006) Pozdnie oslozhneniya terapii bol'nykh limfomoy Khodzhkina
Demina E.A., Pylova I.V., Shmakov R.G., Perilova E.E.
Vol 5, No 3 (2003) Pravitel'stvo Rossiyskoy Federatsii Rasporyazhenie20 marta 2003 g.№357-R
- -.
Vol 27, No 2 (2025) Preclinical studies of cytotoxicity and cytostatic activity of five new imidazotriazine derivatives in MDA-MB231, BT474, and MCF-7 breast cancer cell cultures PDF
(Rus)
Al-Humairi A.H., Buldakov M.A., Novochadov V.V., Cherdyntseva N.V., Udut V.V.
Vol 18, No 2 (2016) Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature PDF
(Rus)
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K.
Vol 19, No 1 (2017) Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer PDF
(Rus)
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Vol 26, No 3 (2024) Predictive modeling of the probability of gynecological complications of tamoxifen therapy: A prospective study PDF
(Rus)
Golubenko E.O., Savelyeva M.I., Korennaya V.V., Podzolkova N.M., Valiev T.T.
Vol 11, No 3 (2009) Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Semiglazov V.F., Semiglazov V.V., Zhil'tsova E.K.
Vol 13, No 4 (2011) Predstaviteli Rossiyskogo onkologicheskogosoobshchestva i Komiteta Soveta Federatsiipo sotsial'noy politike i zdravookhraneniyudogovorilis' sovmestno borot'sya s rakommolochnoy zhelezy v Rossii
- -.
Vol 10, No 1 (2008) Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A.
Vol 4, No 3 (2002) Preimushchestva neoad\"yuvantnoy khimioterapii v lechenii ploskokletochnogo raka organov polosti rta i rotoglotki
Mudunov A.M., Matyakin E.G., Garin A.M., Podvyaznikov S.O., Azizyan R.I.
Vol 23, No 4 (2021) Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma PDF
(Rus)
Klimovich P.S., Rubina K.A., Mironov N.A., Kakotkin V.V., Oleynikova N.A., Mal`kov P.G., Kubyshkin V.A., Galliamov E.A., Agapov M.A., Semina E.V.
Vol 15, No 1 (2013) Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I.V., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Vol 20, No 1 (2018) Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus PDF
(Rus)
Shogenov M.S., Davydov M.M., Allakhverdiyev A.K., Chekini A.K., Filatov A.A., Akhmedov P.I., Serebryanskaya M.V., Korolyeva A.A., Dadyev I.A., Chichikov E.I., Grigorenko V.A., Kozlov N.A., Nazliyev P.B., Malikhova O.A., Tryakin A.A.
Vol 17, No 2 (2015) Preparat Gaziva® stanet dostupen‌‌ dlya terapii patsientov s khronicheskim limfotsitarnym leykozom
- -.
Vol 26, No 3 (2024) Preparing a patient with bowel cancer for surgery with multiple interventions (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review) PDF
(Rus)
Editorial B.
Vol 16, No 4 (2014) Press release
- -.
Vol 17, No 5 (2015) Press release | October 21, 2015XII Annual Russian Conference with International Participation "Malignant Lymphomas" Symposium "New perspectives in the treatment of chronic lymphocytic leukemia"
- -.
Vol 16, No 3 (2014) Press Release. New data show Giotrif® (afatinib) provided more than one year additional survival for patients with lung cancer associated with the most common type of EGFR mutation (del19) compared to chemotherapy
- -.
Vol 16, No 4 (2014) Press releaseThe resolution of the expert council for targeted therapy of radioactive iodine-refractory differentiated thyroid cancer
- -.
Vol 6, No 2 (2004) Press-konferentsiya «Novye rezul'taty v endokrinnoy terapii raka molochnoy zhelezy»
- -.
Vol 16, No 2 (2014) Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI
- -.
Vol 16, No 2 (2014) Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
- -.
Vol 17, No 3 (2015) Press-release Combination treatment with Vargatef® and docetaxel contributes to statistically significant tumor reduction in patients with progressive adenocarcinoma of the lung in comparison with docetaxel in monotherapy
- -.
Vol 16, No 1 (2014) Press-release. The resolution of oncologists of the North-West Federal District: screening for female reproductive system cancers is required
- -.
Vol 10, No 3 (2008) Press-reliz Novaya era v lechenii raka pochki
- -.
Vol 11, No 4 (2009) Press-reliz Glioblastoma: novye gorizonty lekarstvennoy terapii
- -.
Vol 11, No 4 (2009) Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni
- -.
Vol 17, No 1 (2015) Press-reliz‌‌ «Novoe sozvezdie preparatov dlya lecheniya HER2-polozhitel'nogo raka molochnoy zhelezy»: satellitnyy simpozium kompanii «Rosh» v ramkakh bol'shoy konferentsii RUSSCO «Rak molochnoy zhelezy»
- -.
Vol 11, No 3 (2009) Press-reliz Evropeyskaya komissiya utverdila rasshirenie pokazaniy k primeneniyu Avastina, odobriv ego kombinatsiyus dotsetakselom v kachestve terapii 1-y linii dlya lecheniya rasprostranennogo (metastaticheskogo) raka molochnoy zhelezy
- -.
Vol 11, No 3 (2009) Press-reliz Na IV Kongresse Rossiyskogo obshchestva onkourologov v Moskve obsudili targetnuyu terapiyu raka pochki i preimushchestva preparata Neksavar
- -.
Vol 11, No 4 (2009) Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
- -.
Vol 11, No 3 (2009) Press-reliz Novoe protivoopukholevoe soedinenie regorafenib (BAY 73-4506) kompanii «Bayer» obespechilo stabilizatsiyu ili regressiyu u 81% bol'nykh rakom pochki
- -.
Vol 10, No 3 (2008) Press-reliz Novye vozmozhnosti v lechenii raka pecheni
- -.
Vol 15, No 3 (2013) Press-reliz Preparat Avastin® odobren v Rossii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom v 1 i 2-y liniyakh terapii nepreryvno
- -.
Vol 11, No 1 (2009) Press-reliz Targetnaya terapiya nemelkokletochnogo raka legkogo: nastoyashchee i budushchee
- -.
Vol 11, No 1 (2009) Press-reliz Telemost prines radostnuyu vest'
- -.
Vol 11, No 3 (2009) Press-reliz Vektibiks v kombinatsii s khimioterapiey v kachestve pervoy i vtoroy liniy terapii znachitel'no udlinyaet period bez progressirovaniya u bol'nykh metastaticheskim rakom tolstoy i pryamoy kishki.
- -.
Vol 11, No 2 (2009) Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
- -.
Vol 13, No 1 (2011) Press-relizEkspertnyy sovet Rossiyskogo obshchestva onkogematologovDiagnostika i lechenie bol'nykh khronicheskim limfoleykozom vysokogo riska
- -.
Vol 25, No 1 (2023) Prevention of febrile neutropenia in oncological patients: real-world data PDF
(Rus)
Sapozhnikov K.V., Sorokina I.V., Gusev A.V., Sableva N.A., Sokolova V.D., Tolkacheva D.G., Berezina A.M.
Vol 8, No 3 (2006) Preventivnaya limfodissektsiya pri rake gortani i gortanoglotki T3-4N0M0
Boykov V.P.
Vol 11, No 3 (2009) Primenenie Aranozy pri neyroendokrinnykh opukholyakh
Gorbunova V.A., Orel N.F., Kuz'minov A.E.
Vol 14, No 1 (2012) Primenenie belkov teplovogo shokav klinicheskoy onkologii
Shevtsov M.A., Khachatryan V.A., Margulis B.A.
Vol 3, No 1 (2001) Primenenie dotsetaksela v lechenii sarkom myagkikh tkaney u detey
Protsenko R.M., Kolosov P.V., Prostomolotov O.A., Maschan A.A.
Vol 7, No 3 (2005) Primenenie eritropoetina posle vysokodoznoy khimioterapii s transplantatsiey autologichnykh gemopoeticheskikh kletok
Ptushkin V.V., Zhukov N.V., Minenko S.V.
Vol 10, No 2 (2008) Primenenie ftorafura v khimioterapii zlokachestvennykh opukholey
Platinskiy L.V., Bryuzgin V.V.
Vol 3, No 3 (2001) Primenenie G-KSF dlya immunoprofilaktiki gnoyno-septicheskikh oslozhneniy u onkologicheskikh bol'nykh posle obshirnykh khirurgicheskikh vmeshatel'stv
Nekhaev I.V., Sviridova S.P., Kiselevskiy M.V.
Vol 12, No 1 (2010) Primenenie Iressy (gefitiniba)v kachestve terapii pervoy liniidlya lecheniya neoperabel'nykhadenokartsinom legkogo, soderzhashchikhmutatsiyu v gene EGFR
Moiseenko V.M., Protsenko S.A., Semenov I.I., Moiseenko F.V., Levchenko E.V., Matsko D.E., Ivantsov A.O., Ievleva A.G., Mityushkina N.V., Togo A.V., Imyanitov E.N.
Vol 17, No 3 (2015) Primenenie kombinatsii ingibitorov BRAF i MEK u patsientov s BRAF+ metastaticheskoy melanomoy
Vakhabova Y.V.
Vol 7, No 2 (2005) Primenenie kombinatsii navel'bina i kselody v terapii vtoroy linii metastaticheskogo raka molochnoy zhelezy
Kazantseva M.V., Davidenko I.S., Goncharova O.A., Mamaeva E.M.
Vol 10, No 2 (2008) Primenenie kombinatsii T-VER u bol'nykhneseminomnymi germinogennymi opukholyami s plokhim prognozom: predvaritel'nye rezul'taty II fazy issledovaniya
Tryakin A.A., Tyulyandin S.A., Fedyanin M.Y., Sergeev Y.S., Faynshteyn I.A., Polotskiy B.E., Figurin K.M., Zakharova T.I., Garin A.M.
Vol 8, No 1 (2006) Primenenie lenograstima (granotsit) v onkologii
Minenko S.V.
Vol 4, No 3 (2002) Primenenie mabtery (rituksimaba) s antratsiklinosoderzhashchimi kombinatsiyami khimiopreparatov v kachestve pervoy linii lecheniya bol'nykh V-kletochnymi NKhL s neblagopriyatnym prognozom (predvaritel'nye rezul'taty)
Poddubnaya I.V., Kuril'nikov A.Y., Osmanov D.S., Voznyy E.K., Borodkina A.G., Belonogov A.V.
Vol 10, No 3 (2008) Primenenie nizkomolekulyarnykh geparinov dlya lecheniya ostrykh trombozov i tromboembolii legochnykh arteriyu onkologicheskikh bol'nykh
Somonova O.V., Madzhuga A.V., Elizarova A.L., Zubrikhina G.N.
Vol 6, No 3 (2004) Primenenie preparata «Mikosist» dlya profilaktiki i lecheniya posttsitostaticheskikh gribkovykh oslozhneniy u bol'nykh limfoproliferativnymi zabolevaniyami
Fedorov A.B., Rukavitsyn O.A.
Vol 12, No 3 (2010) Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON)
Gorbunova V.A.
Vol 9, No 4 (2007) Primenenie preparata Vero-Fludarabin v terapii limfoproliferativnykh zabolevaniy
Fedorov A.B., Rukavitsyn O.A.
Vol 2, No 2 (2000) Primenenie preparata zofran u bol'nykh, poluchayushchikh tsitostaticheskuyu terapiyu
Bogdanova N.V.
Vol 11, No 2 (2009) Primenenie selena v onkologii
Ognerubova I.N., Poddubnaya I.V.
Vol 10, No 2 (2008) Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I.S., Kupchan D.Z.
Vol 9, No 2 (2007) Primenenie Zomety na fone endokrinnoy terapii Femaroy u bol'nykh rakom molochnoy zhelezy s metastazami v kosti
Konstantinova M.M., Ovchinnikova L.K., Lomakin N.N., Galleev M.G., Neretina E.S., Mukhamedshina G.Z., Mukhametgaleeva F.K.
Vol 6, No 3 (2004) Primenenie zomety v lechenii metastaticheskogo porazheniya skeleta (klinicheskiy opyt)
Aliev M.D., Bolotina L.V., Teplyakov V.V., Koroleva L.A., Karpenko V.Y., Titov D.A.
Vol 19, No 4 (2017) Principles of diagnosis and surgical treatment of patients with retroperitoneal schwannomas PDF
(Rus)
Bugaev V.E., Nikulin M.P., Melikov S.A.
Vol 21, No 4 (2019) Principles of premetastatic niche formation PDF
(Rus)
Korneva Y.S., Ukrainets R.V.
Vol 15, No 2 (2013) Problem of iron-deficiency anemia in patients with cancers: practice in using iron-containing drugs
Snegovoy A.V.
Vol 2, No 2 (2000) Problema osteoporoza i vozmozhnosti primeneniya miakal'tsika v onkologii
Makarenko N.P.
Vol 9, No 2 (2007) Problema prodolzhitel'nosti zhizni bol'nykh zlokachestvennymi opukholyami, poluchayushchikh preparaty-stimulyatory eritropoeza
Pokataev I.A., Tyulyandin S.A.
Vol 4, No 3 (2002) Problema reabilitatsii golosovoy funktsii u laringektomirovannykh bol'nykh
Dvornichenko V.V.
Vol 2, No 4 (2000) Problema tromboembolicheskikh oslozhneniy v onkologii
Davydov M.I.
Vol 11, No 1 (2009) Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
Borisova E.I., Voronina I.Y., Gutorov S.L.
Vol 5, No 4 (2003) Problemy lecheniya nemelkokletochnogo raka legkogo
Poddubnaya I.V.
Vol 3, No 1 (2001) Problemy reabilitatsii v onkopediatrii
Tseytlin G.Y., Pozharskaya G.V., Smirnova Z.V., Kolmanovskaya N.E., Byalik M.A., Gref A.E., Chekulaeva Y.V., Kolmanovskiy A.E.
Vol 5, No 4 (2003) Proekt Programmy izucheniya neoad\"yuvantnoy terapii nemelkokletochnogo raka legkogo IIIA - IIIB stadiy
- -.
Vol 4, No 1 (2002) Proekt regional'noy programmy lecheniya pervichno-generalizovannogo (PGRMZh) i metastaticheskogo raka molochnoy zhelezy (MRMZh)
- -.
Vol 5, No 1 (2003) Proekt Regional'noy programmy lecheniya pervichnykh bol'nykh rakom yaichnikov II'-s-IV stadiy
- -.
Vol 2, No 4 (2000) Profilaktika posleoperatsionnykh venoznykh tromboembolicheskikh oslozhneniy Rossiyskiy konsensus
- -.
Vol 11, No 1 (2009) Profilaktika tromboticheskikh oslozhneniy s pomoshch'yu Fragmina u onkologicheskikh bol'nykh, poluchavshikh khimioterapiyu
Somonova O.V., Madzhuga A.V., Elizarova A.L., Zubrikhina G.N.
751 - 900 of 1398 Items << < 1 2 3 4 5 6 7 8 9 10 > >> 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».